US59064R1095
US59064R1095
Mesa Laboratories, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 713.53M EUR | 557.06M EUR | 488.51M EUR | 433.7M EUR |
Enterprise Value | 834.53M EUR | 671.86M EUR | 616.76M EUR | 585.7M EUR |
Valuation Multiples | ||||
Trailing P/E | 150.01x | 116.05x | 72.78x | 39.98x |
Forward P/E | 12.42x | -- | -- | -- |
Price to Sales | 2.86x | 2.23x | 1.96x | 2.34x |
Price to Book | 3.78x | 2.95x | 2.62x | 2.32x |
EV/Revenue | 3.34x | 2.69x | 2.48x | 3.16x |
EV/EBITDA | 18.37x | 15.56x | 13.41x | 14.93x |
Price to FCF (P/FCF) | 13.37x | 10.54x | 12.34x | 16.66x |
EV/FCF | 15.63x | 12.71x | 15.58x | 22.5x |
FCF Yield | 7.48% | 9.49% | 8.1% | 6% |